Investigation of methicillin-resistant Staphylococcus aureus showing reduced vancomycin susceptibility isolated from a patient with infective endocarditis

被引:6
作者
Takayama, Y
Hanaki, H
Irinoda, K
Kokubun, H
Yoshida, K
Sunakawa, K
机构
[1] Kitasato Univ, Sch Med, Dept Infect Dis, Sagamihara, Kanagawa 2288555, Japan
[2] Kitasato Univ, Sch Med, Dept Microbiol, Sagamihara, Kanagawa, Japan
[3] Kitasato Univ Hosp, Dept Pharm, Sagamihara, Kanagawa, Japan
[4] Kitasato Univ, Sch Med, Dept Urol, Sagamihara, Kanagawa, Japan
关键词
vancomycin; susceptibility MRSA; MRSA; therapeutic drug monitoring; infective endocarditis;
D O I
10.1016/S0924-8579(03)00263-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A patient with infective endocarditis (IE) caused by methicillin-resistant Staphylococcus aureus (MRSA) was treated with vancomycin (VAN). VAN was ineffective, although therapeutic drug monitoring (TDM) indicated that the recommended trough level was maintained. Five MRSA isolates obtained at various times were analyzed to determine the minimum inhibitory concentration (MIC) and were subjected to population analysis, simulation analysis pulsed-field gel electrophoresis (PFGE). MRSA susceptible to VAN was isolated before and during the early stage of treatment, while an MRSA strain showing reduced VAN MIC was isolated during treatment. Simulation analysis indicated that the viable bacterial count only decreased to 10(-3) to 10(-4) cells after 72 h of incubation. The five MRSA strains isolated at various times were identical by PFGE. (C) 2003 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:567 / 573
页数:7
相关论文
共 33 条
[1]   New approach for accurate simulation of human pharmacokinetics in an in vitro pharmacodynamic model:: application to ciprofloxacin [J].
Ba, BB ;
Bernard, A ;
Iliadis, A ;
Quentin, C ;
Ducint, D ;
Etienne, R ;
Fourtillan, M ;
Maachi-Guillot, I ;
Saux, MC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (02) :223-227
[2]   Infective endocarditis, 1984 through 1993: A clinical and microbiological survey [J].
Benn, M ;
Hagelskjaer, LH ;
Tvede, M .
JOURNAL OF INTERNAL MEDICINE, 1997, 242 (01) :15-22
[3]  
*CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1165
[4]   STAPHYLOCOCCUS-AUREUS ENDOCARDITIS - A REVIEW OF 119 CASES [J].
ESPERSEN, F ;
FRIMODTMOLLER, N .
ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (06) :1118-1121
[5]  
*EUR, 2002, GLYC INT STAPH AUR D, V6, P51
[6]  
Ferraz V, 2000, S AFR MED J, V90, P1113
[7]   Community-acquired methicillin-resistant Staphylococcus aureus:: A cause of musculoskeletal sepsis in children [J].
Gwynne-Jones, DP ;
Stott, NS .
JOURNAL OF PEDIATRIC ORTHOPAEDICS, 1999, 19 (03) :413-416
[8]  
Hanaki H, 1999, Kansenshogaku Zasshi, V73, P1048
[9]   Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50 [J].
Hanaki, H ;
Kuwahara-Arai, K ;
Boyle-Vavra, S ;
Daum, RS ;
Labischinski, H ;
Hiramatsu, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :199-209
[10]  
HANAKI H, 1999, ANTIBIOT CHEMOTHER, V15, P575